About Enhancer
| Enhancer ID: | E_01_0142 |
| Species: | human |
| Position : | chr17:43751254-43753254   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Osteoporosis |
| Pubmed ID: | 29569934 |
| Enhancer experiment: | Luciferase reporter assay,ChIP,qPCR |
| Enhancer experiment description: | The SOST gene encodes sclerostin, a C-terminal cysteine knot-like domain containing key negative regulator of osteoblastic bone formation that inhibits LRP5/6-mediated canonical Wnt signaling. |
About Target gene
| Target gene : | SOST(5430411E23Rik) |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | The SOST gene encodes sclerostin, a C-terminal cysteine knot-like domain containing key negative regulator of osteoblastic bone formation that inhibits LRP5/6-mediated canonical Wnt signaling. |
About TF
| TF name : | -- |
| TF experiment: | Luciferase reporter assay,ChIP,qPCR |
| TF experiment description: | The SOST gene encodes sclerostin, a C-terminal cysteine knot-like domain containing key negative regulator of osteoblastic bone formation that inhibits LRP5/6-mediated canonical Wnt signaling. |
About Function
| Enhancer function : | The SOST gene encodes sclerostin, a C-terminal cysteine knot-like domain containing key negative regulator of osteoblastic bone formation that inhibits LRP5/6-mediated canonical Wnt signaling. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
The SOST gene encodes sclerostin, a C-terminal cysteine knot-like domain containing key negative regulator of osteoblastic bone formation that inhibits LRP5/6-mediated canonical Wnt signaling. |
About SNP
| SNP ID: | rs1230399,rs7220711,rs1107748,rs75901553 |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene